Advertisement

Topics

New high-throughput screening study may open up for future Parkinson's disease therapy

20:00 EDT 9 Sep 2018 | AAAS

(Aarhus University) Parkinson's disease is the most common neurodegenerative diseases; currently there is no cure. Aggregation of the protein α-synuclein plays a key role in this disease. Together with a US drug company, Researchers from Aarhus University have now carried out a new screening strategy which has identified novel and structurally diverse aggregation inhibitors.

Original Article: New high-throughput screening study may open up for future Parkinson's disease therapy

NEXT ARTICLE

More From BioPortfolio on "New high-throughput screening study may open up for future Parkinson's disease therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...